share_log

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities

SEC ·  May 19, 2022 11:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more